A Shot in the Dark: Are Intrathecal Therapies Effective for NMDA Receptor Encephalitis?

Leading Insights, Pharmacy

A Shot in the Dark: Are Intrathecal Therapies Effective for NMDA Receptor Encephalitis?

Written By: Nicolas Chiriboga, MD; Jose Irazuzta, MD

Autoimmune encephalitis (AIE) is a very frequently diagnosed type of encephalitis in middle-to-high-income countries.

Neurocritical care society

Neurocritical Care Insights And
Perspectives From Around the World

Join Our Mailing List

Leading Insights

Virtual Reality for Neurorehabilitation: Mechanisms, Modalities, and Clinical Applications

Written By: Shane Musick, MD; Nilufer Yalcin, MD

Virtual reality (VR) has transitioned from a speculative technology to a clinically validated tool in neurorehabilitation, offering unique opportunities to address the complex needs of neurocritical care patients.

NCS News

Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial

Written By: William Spears, MD

Background: The recently published ARCADIA trial, which enrolled patients with ESUS and signs of atrial cardiopathy, failed to show that treatment with anticoagulation prevented recurrent ischemic stroke.

Leading Insights, International

Artificial Intelligence in Neurocritical Care: Perspectives from National Representatives of the NCS Asia Oceania Chapter

Written By: Gentle S Shrestha, MD, FNCS; Andrew Udy, PhD, FCICM; Girija P Rath, MD, DM; Masao Nagayama, MD, PhD; Prashant Kumar, MD, MBA, FICCM; Saurabh Anand, MBBS, MD; et al.